开放期刊系统

基于在线问答社区的褪黑素回答文本的主题特征与情感倾向

庞 盼杏, 刘 奕, 杨 南哲, 陈 卓岚, 徐中 岳*

摘要

目的:探讨有关褪黑素文本信息的主题特征与情感倾向。方法:以知乎问答社区中有关褪黑素的问答信息为数据源,
使用隐含狄利克雷分布题模型、朴素贝叶斯模型进行主题分析与情感分析,结合词云图、主题特征趋势图进行描述。结果:
社区用户回答文本主题包括:服用经历与感受、其他调节睡眠建议、褪黑素性质、副作用、产品推荐。社区用户对褪黑素
的情感大多保持负向与中性。结论:社区用户存在不合理使用行为,褪黑素助眠效果有个体差异性。建议用户寻找失眠的
真正原因,采用科学方法改善睡眠,建议平台鼓励医药专业人士入驻社区,指导合理使用褪黑素,增加科普内容。

关键词

褪黑素;问答社区;主题特征;情感分析

全文:

PDF

参考

[1] 腾讯新闻 . 睡眠健康行业研究报告:助眠需求日益

增长,睡眠经济市场广阔 [EB/OL].(2021-11-20)[2024-04-02].

https://new.qq.com/rain/a/20211120A01V4K00

[2] 中 国 食 品 报 . 千 亿 规 模 助 眠 市 场 悄 然 苏 醒 [EB/

OL].(2020-01-19)[2024-04-02].https://www.cnfood.cn/

article?id=1483612464428056578.

[3]CLAYTON V, JENNIFER M, KAYLA P. Circadian

Rhythm Dysregulation and Restoration: The Role of Melatonin[J].

Nutrients,2021,13(10):3480.

[4]ROBERT R A, J H B, S J E, et al. Clinical Practice

Guideline for the Treatment of Intrinsic Circadian Rhythm

Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder

(ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD),

Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and

Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for

2015: An American Academy of Sleep Medicine Clinical Practice

Guideline[J] .J Clin Sleep Med, 2015,11(10):1199-1236.

[5]C M F B, J M V. Adverse events in long-term studies of

exogenous melatonin [J].Expert Opin Drug Saf. 2022;21(12):1469-

1481.

[6]ZIMMERMAN JOEL T, SCHREIBER SARA J,

HUDDLELAUREN N. Case Report of Lethal Concentrations

of the Over-the-Counter Sleep Aids Diphenhydramine and

Melatonin[J].The American journal of forensic medicine and

pathology,2023,44(3):227-230.

[7]J.J. P, M. P, J.J. A O, et al. Melatonin in sleep disorders[J].

Neurología (English Edition),2020,37(7):575-585.

[8]H. J C, SAUMYA B, H. C K, et al. Anti-inflammatory

effects of melatonin: A systematic review and meta-analysis of

clinical trials[J]. Brain Behav Immun, 2021;93:245-253.

[9]GEORGETA B, M. R S, ZORICA J, et al. Protective Role

of Melatonin and Its Metabolites in Skin Aging[J].International

Journal of Molecular Sciences,2022,23(3):1238.

[10]SANKHA B, KUMAR K P, DEEPA D, et al. Melatonin

and its ubiquitous anticancer effects.[J].Molecular and cellular bio

chemistry,2019,462(1-2):133-155.

[11]ROMA P, NISHANT P, SAYANTANI P P, et

al. Diabetes mellitus and melatonin: Where are we?[J].

Biochimie,2022;202:2-14.

[12]CATERINA F, EDOARDO S, GAIA F, et al. Essential

Hypertension and Oxidative Stress: Novel Future Perspectives[J].

International Journal of Molecular Sciences,2022,23(22):14489.

[13]MD. D S, JEONGHYUN C, YUNHO J, et al.

Neurocognitive effects of melatonin treatment in healthy adults and

individuals with Alzheimer’s disease and insomnia: a systematic

review and meta-analysis of randomized controlled trials[J].

Neuroscience Biobehavioral Reviews,2021,127:459-473.

[14]KAKHAKI D R, OSTADMOHAMMADI V, KOUCHAKI

E, et al. Melatonin supplementation and the effects on clinical

and metabolic status in Parkinson’s disease: a randomized,

double-blind, placebo-controlled trial[J].Clinical Neurology and

Neurosurgery,2020,195:105878.

[15]LISA S, MÅNS E, YLVA B, et al. Adjuvant use of

melatonin for pain management in dysmenorrhea - a randomized

double-blinded, placebo-controlled trial[J].European journal of

clinical pharmacology,2021,78(2):1-6.

[16]REZA O T, NAGHMEH M, J R R, et al. Melatonin and

pancreatic cancer: Current knowledge and future perspectives[J].

Journal of cellular physiology,2019,234(5):5372-5378.

[17]NEGIN A, RANA S, J R R, et al. Melatonin is an

appropriate candidate for breast cancer treatment: Based on

known molecular mechanisms[J].Journal of cellular biochemist

ry,2019,120(8):12208-12215.

[18]ROSINSKI P A B, MEDEIROS F S, ALMEIDA I A, et

al. Regulatory aspects and evidences of melatonin use for sleep

disorders and insomnia: an integrative review[J].Arquivos de

neuro-psiquiatria,2021,79(8):732-742.

[19]National Center for Complementary and Integrative

Health (2021). Melatonin: what you need to know[EB/OL].(2024-

5-20)[2024-11-14].Available at:https://www.nccih.nih.gov/

health/melatonin-what-you-need-to-know

[20]KARIMA L, VARUN V, I M N, et al. Pediatric Melatonin

Ingestions - United States, 2012-2021[J]. Morbidity and mortality

weekly report,2022,71(22):725-729.

[21]ALQUTUB T S, ALZAHRANI A F, HASSAN S A, et

al. Exogenous Melatonin Use in University Students: A Cross-

Sectional Survey[J].Pharmacy (Basel, Switzerland),2024,12(2):41.

[22]COLIN T, ELIE M, ZOE S M, et al. Current Insights into

the Risks of Using Melatonin as a Treatment for Sleep Disorders in

Older Adults[J].Clinical interventions in aging,2023,1849-59.

[23]NICOLE M H, KEINKE H A, ANJA U, et al. The

short-term and long-term adverse effects of melatonin treatment

in children and adolescents: a systematic review and GRADE

assessment[J].eClinicalMedicine,2023,61:102083.

[24] 李 菲 菲 , 张 李 伟 , 付 宗 强 等 . 褪 黑 素 类 保 健

食 品 注 册 审 评 审 批 状 况 分 析 与 建 议 [J]. 食 品 与 发 酵 工

业 ,2020,46(07):283-288.

[25] 邵明坤 , 刘蓉 , 孙品等 . 褪黑素人体网络机制及其

临床应用 [J]. 中国临床药理学与治疗学 ,2022,27(09):1031-

1040.

[26] 国家市场监督管理总局 . 关于发布辅酶 Q10 等五

种保健食品原料目录的公告 [EB/OL].(2020-12-01)[2024-04-

09].https://www.samr.gov.cn/zw/zfxxgk/fdzdgknr/tssps/art/2023/art

_501802c47f05470ab9653d7001c94071.html

[27] 周国韬 , 龚栩 , 邓胜利 . 基于主题分析的用户养生

健康信息需求演化趋势研究 [J]. 情报科学 ,2022,40(04):118-

126+137.

[28] 朱光 , 颜燚 . 双重信任视角下社会化问答社区知识

付费意愿的影响机制研究 [J]. 情报科学 ,2024,42(03):52-63.

[29] 胡桂梅 , 陈娟艺 , 言欢 . 社会化问答平台测评信息

特征对用户参与行为的影响研究——以知乎为例 [J]. 情报科

学 ,2024,42(03):139-146.

[30] 张东鑫 , 张敏 . 图情领域 LDA 主题模型应用研究进

展述评 [J]. 图书情报知识 ,2022,39(06):143-157.

[31]ADILAH T M, M A T, HENDRA S, et al. Sentiment

Analysis of Online Transportation Service using the

Naïve Bayes Methods[J].Journal of Physics: Conference

Series,2020,1641(1):012093.

[32]RIEMANN D, ESPIE A C, ALTENA E, et al.

The European Insomnia Guideline: An update on the

diagnosis and treatment of insomnia 2023[J].Journal of Sleep

Research,2023,32(6):e14035.

[33]GRANDNER MICHAEL A. Sleep, Health, and

Society[J].Sleep Medicine Clinics,2022,17(2):117-139.

[34]]Antony M S, Debbie O, J M B, et al. A randomized

double-blind placebo-controlled trial of treatment as usual

plus exogenous slow-release melatonin (6 mg) or placebo for

sleep disturbance and depressed mood[J]. International Clinical

Psychopharmacology. 2010;25(3):132-142.

[35]PERUMAL P, CHANG S, DE A, et al. Slow release

exogenous melatonin modulates scrotal circumference and

testicular parameters, libido, endocrinological profiles and

antioxidant and oxidative stress profiles in mithun[J].Theriogenolo

gy,2020,154(prepublish):1-10.


(5 摘要 Views, 6 PDF Downloads)

Refbacks

  • 当前没有refback。